MoonLake Immunotherapeutics

MLTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$12.55

+$0.16 (+1.29%)

At close: Sep 21, 2026, 4:00 PM ET

$12.60

+$0.05 (+0.40%)

Pre-market: Sep 22, 2026, 8:33 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	2.62M	n/a	n/a	n/a	4.97K	n/a
Gross Profit	-2.62M	n/a	n/a	n/a	-4.97K	n/a
Operating Income	-244.83M	-143.09M	-54.12M	-65.06M	-53.58M	-105.76K
Interest Income	n/a	n/a	n/a	n/a	n/a	14.92K
Pretax Income	-229.71M	-120.96M	-43.98M	-64.47M	-53.64M	-90.84K
Net Income	-227.32M	-118.94M	-36.01M	-49.97M	-53.64M	-90.84K
Selling & General & Admin	41.97M	30.32M	22.32M	23.01M	18.05M	105.76K
Research & Development	202.86M	112.77M	31.8M	42.05M	35.52M	n/a
Other Expenses	-2.62M	n/a	n/a	n/a	n/a	n/a
Operating Expenses	242.22M	143.09M	54.12M	65.06M	53.57M	105.76K
Interest Expense	7.25M	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	244.83M	143.09M	54.12M	65.06M	53.58M	105.76K
Income Tax Expense	611K	282.2K	94.39K	36.37K	4.76K	n/a
Shares Outstanding (Basic)	64.46M	62.87M	49.12M	29.36M	36.93M	14.81M
Shares Outstanding (Diluted)	64.46M	62.87M	49.12M	29.36M	36.93M	14.81M
EPS (Basic)	-3.53	-1.89	-0.73	-2.20	-1.45	-0.01
EPS (Diluted)	-3.53	-1.89	-0.73	-2.20	-1.45	-0.01
EBITDA	-219.85M	-119.58M	-43.61M	-64.3M	-53.63M	-90.84K
EBIT	-222.46M	-120.96M	-43.98M	-64.47M	-53.64M	-90.84K
Depreciation & Amortization	2.62M	1.38M	370.32K	164.78K	4.97K	n/a